Malignant Neoplasm Of Bladder Unspecified
- 2016201720182019202020212022Billable/Specific Code
- C67.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2022 edition of ICD-10-CM C67.9 became effective on October 1, 2021.
- This is the American ICD-10-CM version of C67.9 – other international versions of ICD-10 C67.9 may differ.
- Applicable To annotations, or
Malignant Neoplasm Of Unspecified Lacrimal Gland And Duct
ICD-10 code C69.50 for Malignant neoplasm of unspecified lacrimal gland and duct
ICD-10
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10
ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems , a medical classification list by the World Health Organization .
It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.
ATC
The Anatomical Therapeutic Chemical Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.
It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology .
DDD
The defined daily dose is a statistical measure of drug consumption, defined by the World Health Organization .
It is used to standardize the comparison of drug usage between different drugs or between different health care environments.
Start And Spread Of Bladder Cancer
The wall of the bladder has many several layers. Each layer is made up of different kinds of cells .
Most bladder cancers start in the innermost lining of the bladder, which is called the urothelium or transitional epithelium. As the cancer grows into or through the other layers in the bladder wall, it has a higher stage, becomes more advanced, and can be harder to treat.
Over time, the cancer might grow outside the bladder and into nearby structures. It might spread to nearby lymph nodes, or to other parts of the body.
Read Also: Can A Bladder Infection Cause Bleeding
Papillary Vs Flat Cancer
Bladder cancers are also divided into 2 subtypes, papillary and flat, based on how they grow .
- Papillary carcinomas grow in slender, finger-like projections from the inner surface of the bladder toward the hollow center. Papillary tumors often grow toward the center of the bladder without growing into the deeper bladder layers. These tumors are called non-invasive papillary cancers. Very low-grade , non-invasive papillary cancer is sometimes called papillary urothelial neoplasm of low-malignant potential and tends to have a very good outcome.
- Flat carcinomas do not grow toward the hollow part of the bladder at all. If a flat tumor is only in the inner layer of bladder cells, it’s known as a non-invasive flat carcinoma or a flat carcinoma in situ .
If either a papillary or flat tumor grows into deeper layers of the bladder, it’s called an invasive urothelial carcinoma.
The Icd Code C679 Is Used To Code Bladder Cancer

Bladder cancer is any of several types of cancer arising from the epithelial lining of the urinary bladder. Rarely the bladder is involved by non-epithelial cancers, such as lymphoma or sarcoma, but these are not ordinarily included in the colloquial term “bladder cancer.” It is a disease in which abnormal cells multiply without control in the bladder.
Specialty: |
- DRG Group #656-661 – Kidney and ureter procedures for neoplasm with MCC.
- DRG Group #656-661 – Kidney and ureter procedures for neoplasm with CC.
- DRG Group #656-661 – Kidney and ureter procedures for neoplasm without CC or MCC.
- DRG Group #656-661 – Kidney and ureter procedures for non-neoplasm with MCC.
- DRG Group #656-661 – Kidney and ureter procedures for non-neoplasm with CC.
- DRG Group #656-661 – Kidney and ureter procedures for non-neoplasm without CC or MCC.
- DRG Group #686-688 – Kidney and urinary tract neoplasms with MCC.
- DRG Group #686-688 – Kidney and urinary tract neoplasms with CC.
- DRG Group #686-688 – Kidney and urinary tract neoplasms without CC or MCC.
You May Like: What Are The Best Bladder Control Pads
Malignant Neoplasm Of Urinary Organ Unspecified
- 2016201720182019202020212022Billable/Specific Code
- C68.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2022 edition of ICD-10-CM C68.9 became effective on October 1, 2021.
- This is the American ICD-10-CM version of C68.9 – other international versions of ICD-10 C68.9 may differ.
- Malignant neoplasm of urinary system NOS
- Applicable To annotations, or
Information For Medical Professionals
Index to Diseases and Injuries
References found for the code 188.9 in the Index of Diseases and Injuries:
- nbsp
- bladder urinary 188.9 198.1 233.7 223.3 236.7 239.4
- contiguous sites 188.8
- dome 188.1 198.1 233.7 223.3 236.7 239.4
- NEC
- orifice 188.9 198.1 233.7 223.3 236.7 239.4
- ureteric 188.6 198.1 233.7 223.3 236.7 239.4
- urethral 188.5 198.1 233.7 223.3 236.7 239.4
- sphincter 188.8 198.1 233.7 223.3 236.7 239.4
- trigone 188.0 198.1 233.7 223.3 236.7 239.4
- urachus 188.7 233.7 223.3 236.7 239.4
- wall 188.9 198.1 233.7 223.3 236.7 239.4
- anterior 188.3 198.1 233.7 223.3 236.7 239.4
- lateral 188.2 198.1 233.7 223.3 236.7 239.4
- posterior 188.4 198.1 233.7 223.3 236.7 239.4
You May Like: Why Does My Bladder Leak
Secondary Malignant Neoplasm Of Bladder
ICD-10 code C79.11 for Secondary malignant neoplasm of bladder
ICD-10
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10
ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems , a medical classification list by the World Health Organization .
It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.
ATC
The Anatomical Therapeutic Chemical Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.
It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology .
DDD
The defined daily dose is a statistical measure of drug consumption, defined by the World Health Organization .
It is used to standardize the comparison of drug usage between different drugs or between different health care environments.
Malignant Neoplasm Of Other And Unspecified Urinary Organsc68
Chapter 2 – Neoplasms » Malignant neoplasms of urinary tract » Malignant neoplasm of other and unspecified urinary organs
ICD-10 Subcodes
7 indications for 794 drugs
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED AS IS, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
Center for Research Innovation in Biotechnology 4240 Duncan Avenue, Suite 110 Saint Louis, MO 63110
Also Check: Is Urge Incontinence The Same As Overactive Bladder
What Is Bladder Cancer
Bladder cancer starts when cells that make up the urinary bladder start to grow out of control. As more cancer cells develop, they can form a tumor and, with time, spread to other parts of the body.
The bladder is a hollow organ in the lower pelvis. It has flexible, muscular walls that can stretch to hold urine and squeeze to send it out of the body. The bladder’s main job is to store urine. Urine is liquid waste made by the 2 kidneys and then carried to the bladder through 2 tubes called ureters. When you urinate, the muscles in the bladder contract, and urine is forced out of the bladder through a tube called the urethra.
Personal History Of Malignant Neoplasm Unspecified
- 2016201720182019202020212022Billable/Specific CodePOA Exempt
- bladder Z85.51
Z85.51 Personal history of malignant neoplasm of bladder
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Also Check: Homemade Cat Food For Bladder Stones
Drg Mapping Rules For C679
Diagnostic codes are the first step in the DRG mapping process.
The patient’s primary diagnostic code is the most important. Assuming the patient’s primary diagnostic code is C67.9, look in the list below to see which MDC’s “Assignment of Diagnosis Codes” is first. That is the MDC that the patient will be grouped into.
From there, check the subsections of the MDC listed. The patient will be mapped into the first subsection for which the treatment performed on the patient meet the listed requirements of that subsection.
DRG grouping rules are adjusted each year, so make sure to check the rules for the fiscal year of the patient’s discharge date.
Factors Influencing Health Status And Contact With Health Servicesnote

Recommended Reading: Natural Remedies For Bladder Infection Apple Cider Vinegar
Personal History Of Malignant Neoplasm Of Urinary Tract
- 2016201720182019202020212022Non-Billable/Non-Specific Code
- History of cancer of the urinary bladder
- History of malignant neoplasm of bladder
- Z85.51 is considered exempt from POA reporting.
- 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with mcc
- 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with cc
- 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures without cc/mcc
- 829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures with cc/mcc
- 830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures without cc/mcc
- 843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
- 844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
- 845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc
- : New code
- 2017
Malignant Neoplasm Of Bladder Unspecified C679
The ICD10 code for the diagnosis “Malignant neoplasm of bladder, unspecified” is “C67.9”. C67.9 is a VALID/BILLABLE ICD10 code, i.e it is valid for submission for HIPAA-covered transactions.
- C67.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2019 edition of ICD-10-CM C67.9 became effective on October 1, 2018.
- This is the American ICD-10-CM version of C67.9 – other international versions of ICD-10 C67.9 may differ.
Read Also: Stage 2 Bladder Cancer Prognosis
Personal History Of Malignant Neoplasm Of Bladder
- 2016201720182019202020212022Billable/Specific CodePOA Exempt
- Z85.51 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2022 edition of ICD-10-CM Z85.51 became effective on October 1, 2021.
- This is the American ICD-10-CM version of Z85.51 – other international versions of ICD-10 Z85.51 may differ.
- Applicable To annotations, or
Medications Used For The Treatment Of Bladder Cancer And Associated Icd
This detailed article of codes related to bladder cancer is intended to assist practice managers and other healthcare providers and payers to ensure the proper use of coding and billing information associated with the treatment of patients with bladder cancer.
The following sections include:
- Associated ICD-10-CM codes used for the classification of bladder cancer
- Drugs that have been approved by the FDA for the treatment of bladder cancer
- Drugs that are Compendia-listed for off-label use for bladder cancer based on clinical studies that suggest beneficial use in some cases. Please note: If a check mark appears in the FDA column, it will NOT appear in the Compendia off-label use column
- Corresponding HCPCS/CPT® codes and code descriptions
- Possible CPT® administration codes for the drugs
Also Check: Tb Virus Treatment For Bladder Cancer
Personal History Of Malignant Neoplasm
- 2016201720182019202020212022Non-Billable/Non-Specific Code
- personal history of benign neoplasm
- personal history of carcinoma-in-situ
- alcohol use and dependence
- exposure to environmental tobacco smoke
- history of tobacco dependence
- occupational exposure to environmental tobacco smoke
Codes Have Changed Guidelines Havent
Obviously, the codes themselves have changed, but the guidelines are identical. If all offices were to follow these guidelines and payers were restricting payment only to correctly diagnosed encounters, the following ICD-9 diagnoses would be reported :
- V58.12 Encounter For Other And Unspecified Procedures And Aftercare: Encounter For Chemotherapy And Immunotherapy For Neoplastic Conditions: Encounter For Antineoplastic Immunotherapy
- 188.2 Malignant Neoplasm Of Bladder: Lateral Wall Of Urinary Bladder
For ICD-10 Dx coding for BCG in treatment phase:
- V58.12 Encounter For Antineoplastic Immunotherapy
- C67.2 Malignant neoplasm of lateral wall of bladder
Once the patient has completed BCG treatment or is deemed in the patient record to be free of cancer and is moved to surveillance cystoscopy to monitor for recurrence, ICD-9 and ICD-10 provide the following guidelines for coding.
ICD-9/Chapter 2: Neoplasms /General guidelines
d. Primary malignancy previously excised
ICD-10/Chapter 2: Neoplasms /General guidelines
d. Primary malignancy previously excised
Based on these guidelines, Dx coding for visits in which surveillance cystoscopy is performed and the results of the cystoscopy are negative or the bladder is noted to be clear should be as follows:
- ICD-9: V10.51 Personal History Of Malignant Neoplas: Urinary Organ: Bladder
- ICD-10: Z86.51 Personal history of malignant neoplasm of bladder.
NEXT: Look at how you’re coding in your own practice
Read Also: Prognosis Of Bladder Cancer In Females
Malignant Neoplasm Of Bladder
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10
ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems , a medical classification list by the World Health Organization .
It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.
ATC
The Anatomical Therapeutic Chemical Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.
It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology .
DDD
The defined daily dose is a statistical measure of drug consumption, defined by the World Health Organization .
It is used to standardize the comparison of drug usage between different drugs or between different health care environments.
You Have Bladder Cancer

The tissue in the body is made up of cells. With cancer, the cells multiply uncontrollably, which leads to a malignant neoplasm developing. The cancer cells can destroy the healthy tissue and spread throughout the body.
The bladder sits low down in the abdomen and collects the urine. The urine is produced in the two kidneys. The urine flows from the kidneys into the bladder via the ureters. When you pass water, the urine flows from the bladder via the urethra and out.
Recommended Reading: Bladder Pain But No Infection
Secondary Malignant Neoplasm Of Unspecified Urinary Organs
ICD-10 code C79.10 for Secondary malignant neoplasm of unspecified urinary organs
ICD-10
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10
ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems , a medical classification list by the World Health Organization .
It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.
ATC
The Anatomical Therapeutic Chemical Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.
It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology .
DDD
The defined daily dose is a statistical measure of drug consumption, defined by the World Health Organization .
It is used to standardize the comparison of drug usage between different drugs or between different health care environments.